Menu

TRACON Pharmaceuticals, Inc. TCON

Full chart Compare
Set alert

Price alert · TCON

All alert types
0.03 0.00 (+0.00%)

At closeJul 16, 2025, 4:00 PM EDT

0.0322 Day range 0.04
0.60 52-week range 17.55
YTD
0.00%
1 year
-94.82%

Revenue & Expenses

Other Income → Expenses: $12.99MExpenses → Selling, General & Admin: $6.67MExpenses → Research & Development: $12.28MExpenses → Other Operating Expenses: $2.38MExpenses → Interest Expense: $7.30MGross Profit → Expenses: $12.04MRevenue → Gross Profit: $12.04MNet Loss → Expenses: $3.59MOther Income$12.99MGross Profit$12.04MNet Loss$3.59MExpenses$28.62MSelling, General & Admin$6.67MResearch & Development$12.28MOther Operating Expenses$2.38MInterest Expense$7.30MRevenue$12.04M

Latest period ending Dec 31, 2023 · select a line to chart its full history

TCON annual income statement
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
12.04M0346.00K00
12.04M0346.00K00
-9.27M-27.89M-28.35M-16.22M-22.30M
-3.59M-29.14M-28.67M-16.77M-22.67M
-2.20-27.80-33.20-37.40-149.40
TCON annual balance sheet
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
8.64M17.50M24.07M32.13M16.41M
10.11M19.47M26.56M37.44M18.12M
10.91M26.62M14.84M12.37M15.42M
-809.00K-7.15M11.71M25.07M2.70M
TCON annual cash flow
Fiscal yearFY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019
3.68M-26.24M-22.57M-17.04M-23.65M
-12.54M19.68M10.56M36.76M906.00K
-8.86M-6.57M-8.06M15.72M-8.72M